![](/img/cover-not-exists.png)
Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease
Tadayasu Togawa, Ikuo Kawashima, Takashi Kodama, Takahiro Tsukimura, Toshihiro Suzuki, Tomoko Fukushige, Takuro Kanekura, Hitoshi SakurabaVolume:
399
Year:
2010
Language:
english
Pages:
721
DOI:
10.1016/j.bbrc.2010.08.006
File:
PDF, 400 KB
english, 2010